GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $488,000 | -12.7% | 11,217 | -12.7% | 0.10% | +4.2% |
| Q1 2022 | $559,000 | -0.2% | 12,842 | +1.2% | 0.10% | +5.5% |
| Q4 2021 | $560,000 | +20.7% | 12,692 | +4.5% | 0.09% | +2.2% |
| Q3 2021 | $464,000 | +0.7% | 12,147 | +5.0% | 0.09% | -15.2% |
| Q2 2021 | $461,000 | -3.2% | 11,572 | -13.3% | 0.10% | -8.7% |
| Q1 2021 | $476,000 | -0.2% | 13,347 | -0.3% | 0.12% | +1.8% |
| Q4 2020 | $477,000 | -25.9% | 13,391 | -21.7% | 0.11% | -37.9% |
| Q3 2020 | $644,000 | -17.5% | 17,107 | -10.7% | 0.18% | -19.8% |
| Q2 2020 | $781,000 | +7.1% | 19,153 | -0.4% | 0.23% | -7.7% |
| Q1 2020 | $729,000 | -20.1% | 19,229 | -1.0% | 0.25% | +2.9% |
| Q4 2019 | $912,000 | +11.2% | 19,415 | +1.0% | 0.24% | +3.0% |
| Q3 2019 | $820,000 | +0.1% | 19,222 | -5.1% | 0.23% | -2.1% |
| Q2 2019 | $819,000 | +2459.4% | 20,246 | +2354.1% | 0.24% | +1381.2% |
| Q3 2018 | $32,000 | – | 825 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chubb Ltd | 400,000 | $15,404,000 | 6.76% |
| KAHN BROTHERS GROUP INC | 833,315 | $32,090,960,000 | 5.42% |
| Sio Capital Management, LLC | 180,811 | $6,963,000 | 4.06% |
| Sio Capital Management, LLC | 170,000 | $6,547,000 | 3.82% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,124,462 | $43,304,000 | 3.12% |
| Keystone Financial Planning, Inc. | 120,705 | $4,648,000 | 3.04% |
| PVG Asset Management | 186,553 | $7,184,156,000 | 3.02% |
| P.R. Herzig & Co. Inc. | 37,950 | $1,461,000 | 2.98% |
| EQUITY INVESTMENT CORP | 2,329,469 | $89,708,000 | 2.89% |
| Sterneck Capital Management, LLC | 114,816 | $4,422,000 | 2.84% |